Pegylated interferon

"Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected

（原始内容存档于2022-07-06）.  Clinical trial number NCT01193699 for "Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera (PEGINVERA)" at ClinicalTrials

Sarin SK, et al. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

AFGANSNNPDWDFNPNKDHWPEANKVG-NH2 Deterding K, Wedemeyer H. Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta. AIDS Reviews. 2019, 21

研究阐明病理生理学的潜力。 其中一项成功案例与识别与抗丙型肝炎病毒治疗反应相关的遗传变异有关。对于用Pegylated interferon alfa-2a 或Pegylated interferon alfa-2b 联合利巴韦林（英語：Ribavirin，俗称'病毒唑'）治疗的 1 型丙型肝炎，GWA